Conceived and designed the experiments: CBB RS. Performed the experiments: DR. Analyzed the data: DR ETW RS. Wrote the paper: DR CBB RS.
The parts of the genome transcribed by a cell or tissue reflect the biological processes and functions it carries out. We characterized the features of mammalian tissue transcriptomes at the gene level through analysis of RNA deep sequencing (RNA-Seq) data across human and mouse tissues and cell lines. We observed that roughly 8,000 protein-coding genes were ubiquitously expressed, contributing to around 75% of all mRNAs by message copy number in most tissues. These mRNAs encoded proteins that were often intracellular, and tended to be involved in metabolism, transcription, RNA processing or translation. In contrast, genes for secreted or plasma membrane proteins were generally expressed in only a subset of tissues. The distribution of expression levels was broad but fairly continuous: no support was found for the concept of distinct expression classes of genes. Expression estimates that included reads mapping to coding exons only correlated better with qRT-PCR data than estimates which also included 3′ untranslated regions (UTRs). Muscle and liver had the least complex transcriptomes, in that they expressed predominantly ubiquitous genes and a large fraction of the transcripts came from a few highly expressed genes, whereas brain, kidney and testis expressed more complex transcriptomes with the vast majority of genes expressed and relatively small contributions from the most expressed genes. mRNAs expressed in brain had unusually long 3′UTRs, and mean 3′UTR length was higher for genes involved in development, morphogenesis and signal transduction, suggesting added complexity of UTR-based regulation for these genes. Our results support a model in which variable exterior components feed into a large, densely connected core composed of ubiquitously expressed intracellular proteins.
A variety of genes are active within the nuclei of our cells. Some are needed for the day-to-day maintenance of cell functions, while others have roles that are more specific to certain tissues or particular cell types; for example, only the pancreas produces insulin. As a result, every tissue has its own profile of gene activity. Since active genes produce RNA, tissue differences in gene activity can be probed by characterizing the RNA they contain. Essentially the entire set of RNAs or ‘transcriptome’ has been sequenced from various tissues, and we used these data to compare the degree of specialization of different tissues and to investigate the set of ‘core’ genes active in every tissue. A central observation was that there are an abundance of such core genes, and that these genes account for the majority of the transcriptome in each tissue. These findings will aid in the understanding of what makes tissues, and cell types, different from each other and what each requires to function.
A fundamental question in molecular biology is how cells and tissues differ in gene expression and how those differences specify biological function. A related question is what part of the cellular machinery represents housekeeping functions needed by all cells and how many genes encode such functions. The transcriptomes of mammalian tissues have been extensively studied using methods such as reassociation kinetics (Rot)
Reassociation kinetics was used early on to study and compare global properties of tissue transcriptomes
Deep sequencing of RNAs (RNA-Seq) has recently been used to quantify gene and alternative isoform expression levels
We recently studied alternative isoform expressions across tissues using RNA-Seq and found both a very high frequency of alternative splicing and extensive tissue regulation of the expression of alternative mRNA isoforms
We investigated the transcriptomes of a diverse collection of human and mouse tissues and five breast and breast cancer cell lines that were recently sequenced at a depth of roughly 20 million short reads per sample using RNA-Seq protocols (
We next sought to answer how many genes are expressed in a tissue or cell type. A comparison between the expression levels of exons and intergenic regions was used to first find a threshold for detectable expression above background (
(A) False discovery and negative rate for the detection of genes as a function of detection threshold used, demonstrating how a threshold of 0.3 RPKM was chosen. (B) The number of genes detected (>0.3 RPKM) at different sequencing depths. Each curve represents a sample. Above 3 million reads the sequence depth matters little for how many genes are detected as expressed. (C) The number of ubiquitous genes (expressed >0.3 RPKM in all samples) as a function of the number of samples used. Error bars show the standard variation, black line the mean. (D) The fraction of genes among ubiquitous and other genes with CpG-poor (purple), intermediate (yellow) or CpG-rich (green) promoters. (E) Illustration of subcellular localizations aligned to protein functional and localization categories for significant categories enriched in ubiquitously expressed genes (blue) and genes that were only expressed in one or a few tissues (red). For each category we have plotted the fraction of all genes that were not ubiquitous (the overall fraction of non-ubiquitous genes are shown as a vertical dashed line). Extracellular functions and membrane functions were highly enriched for non-ubiquitous genes while intracellular functions were dominated by ubiquitous genes. The categories shown are a subset of all significant categories listed in
| Threshold RPKM | In all 24 samples | On average per sample |
| 0.01 | 10,233 | 14,885 |
| 0.1 | 9,205 | 14,011 |
| 0.2 | 8,466 | 13,327 |
| 0.3 | 7,897 | 12,859 |
| 0.4 | 7,388 | 12,489 |
| 0.5 | 6,946 | 12,170 |
| 0.6 | 6,535 | 11,887 |
| 0.7 | 6,176 | 11,633 |
| 0.8 | 5,898 | 11,401 |
| 0.9 | 5,618 | 11,189 |
| 1 | 5,361 | 10,989 |
| 2 | 3,510 | 9,432 |
| 3 | 2,513 | 8,340 |
| 4 | 1,931 | 7,493 |
| 5 | 1,548 | 6,804 |
| Tissue/Cell | Number of genes |
Fraction of genes |
Ensembl genes |
| Skeletal muscle |
11,276 | 0.61 | 11,953 |
| Liver |
11,392 | 0.61 | 12,191 |
| BT474 |
11,844 | 0.64 | 12,808 |
| MB435 |
11,847 | 0.64 | 12,726 |
| HME |
12,084 | 0.65 | 12,920 |
| T47D |
12,205 | 0.66 | 12,983 |
| Heart | 12,209 | 0.66 | 13,159 |
| MCF7 |
12,281 | 0.66 | 13,216 |
| Adipose tissue | 12,553 | 0.68 | 13,503 |
| Colon | 13,016 | 0.70 | 14,052 |
| Cerebellum |
13,132 | 0.70 | 14,043 |
| Kidney | 13,235 | 0.71 | 14,177 |
| Brain |
13,298 | 0.71 | 14,107 |
| Breast | 13,406 | 0.72 | 14,537 |
| Lymph node | 13,534 | 0.73 | 14,686 |
| Testes | 15,518 | 0.84 | 16,869 |
*annotations from RefSeq, protein-coding genes.
†number of protein-coding genes, annotations from Ensembl.
number of genes detected in mouse: skeletal muscle 11,799; liver 11,201; brain 13,626.
standard deviation for samples from different individuals: 106.
mean number for different individuals.
breast cancer cell line.
human mammary epithelial cell line.
| Tissue/Cell | Fraction ubiquitous |
| Liver |
0.31 |
| Heart | 0.66 |
| Brain | 0.74 |
| HME |
0.75 |
| Breast | 0.75 |
| Skeletal muscle | 0.76 |
| Cerebellum |
0.76 |
| Testes | 0.77 |
| Kidney | 0.78 |
| Adipose tissue | 0.81 |
| Colon | 0.82 |
| Lymph node | 0.84 |
| T47D |
0.87 |
| MB435 |
0.89 |
| MCF7 |
0.89 |
| BT474 |
0.90 |
standard deviation for samples from different individuals: 0.01.
mean number for different individuals.
breast cancer cell line.
human mammary epithelial cell line.
To characterize the set of ubiquitously expressed genes we had identified, we looked for functional enrichment compared to genes expressed only in a subset of the tissues analyzed (hereafter called non-ubiquitous). The protein products of human ubiquitously expressed genes were more likely to have intracellular localization and to be involved in metabolism and other core cellular functions such as macromolecule synthesis, general transcription and vesicles (
| Transcription factor classification | Number of genes | Fraction non-ubiquitous |
| POU | 14 | 0.93 |
| Homedomain | 239 | 0.89 |
| Forkhead | 41 | 0.78 |
| ETS | 28 | 0.71 |
| Helix-loop-helix | 86 | 0.67 |
| p53 family | 42 | 0.67 |
| Other | 152 | 0.66 |
| Nuclear hormone receptor | 47 | 0.66 |
| Zinc finger, C2H2 | 623 | 0.61 |
| High mobility group | 39 | 0.59 |
| IPT/TIG |
17 | 0.47 |
| Basic-leucine zipper | 53 | 0.42 |
IPT: Immunoglobin-like fold shared by Plexins and Transcription factors; TIG: Transcription factor ImmunoGlobin.
As RNA-Seq expression measurements are highly quantitative, we also explored tissue transcriptome composition in terms of mRNA abundance classes
(A) The fraction of all mRNAs derived from the most highly expressed genes for a number of mouse and human tissues. For example, the 10 most expressed genes in mouse liver contribute 25% of all mRNAs in that tissue. (B) Same as A, but with cell lines from breast. HME is a transformed cell line from normal mammary epithelium, breast is the normal tissue, the others are breast cancer cell lines from invasive ductal carcinoma. Gray lines are the tissues in A. (C) Same as B, but with 2 human livers and 6 human cerebellar samples from different individuals, to illustrate the degree of reproducibility in this type of plot and little inter-individual variation. (D) Same as B, but with three tissues from mouse.
In muscle and liver transcriptomes, a small number of genes contributed a large fraction of the total mRNA pool, e.g. the ten most highly expressed genes in liver and muscle made up roughly 20–40% of the mRNA population. Other tissue transcriptomes were more complex, with the ten most highly expressed genes contributing only 5–10% of the mRNAs in brain, kidney and testis. The remaining tissues had intermediate levels of complexity (
We next asked what fractions of total cellular mRNA are allocated to genes involved in different biological processes across the different tissues and cell lines. For this purpose, we developed a tool called FRACT (
(A) Pie graphs show estimated fraction of cellular transcripts deriving from genes belonging to a set of top-level Gene Ontology Biological Process categories for 7 human tissues and 1 cell line. Fractions were estimated from read density (RPKM) of Ensembl transcripts for each gene. Names of categories, distribution of transcriptome fraction across the samples (each line is a sample), and the coefficients of variation are shown at right. Biological processes with significantly higher or lower densities in individual tissues and cell lines are denoted by arrows. (B) FRACT analysis of sub-categories of the top-level ‘Development’ category in brain and testes.
We also investigated the expression of thousands of large non-coding RNAs (ncRNAs). These genes were found to contribute a small fraction of transcripts to polyA+ transcriptomes compared to mRNAs (
(A) Relative fractions of polyA+ transcripts from protein-coding RNA (mRNA), curated non-coding RNA (ncRNA) and lincRNA, presented as the mean across human tissues. (B) The number of genes above a particular RPKM threshold (in one or more tissues) as a function of the threshold. (C) The maximum tissue expression level of mRNAs, curated ncRNAs and lincRNAs as a function of the number of tissues with detected expression. The average and standard deviations of the max expression levels in each group of genes are shown.
Muscle and brain tissues from human and mouse were observed to have similar expression and FRACT distributions (
The lengths of mRNAs were studied by mapping the reads to coding and untranslated regions. Using RefSeq annotations, the density of reads in untranslated regions was lower than in coding regions (
(A) Read density in RefSeq gene annotation in the untranslated regions (UTRs) divided by that in the coding region (CDS) for the samples with least 3′ bias (mouse brain, muscle, embryonic stem cell and embryoid body; human adipose tissue and heart). Vertical lines indicate mean values. (B) Plot of mRNA length against abundance in mouse liver, showing that short mRNAs tend to have more copies. Pearson correlation and the number of mRNAs plotted are listed. (C) Expression-weighted average lengths of all mRNAs in three mouse tissues.
To assess the protein functions encoded by transcripts with long or short UTRs, we calculated the median length of 5′ and 3′UTRs of genes associated with each GO biological process category (
(A) The length distribution of 3′UTRs for genes in categories with the shortest respectively longest UTRs. The 25, 50 and 75% percentile lengths for each GO biological process category are presented. (B) The distribution of median lengths across all GO biological process categories.
A surprise in our analysis was the large number of ubiquitous genes found expressed in all tissues and cell lines, and that these genes account for a majority of the mRNA pool. This pattern suggests that tissue identity derives less from expression of distinct sets of genes in different tissues than was previously thought. Ubiquitous genes can still vary in relative expression levels between tissues however, and in expression of alternative mRNA isoforms
Transcriptome complexity varied substantially across tissues, with brain, kidney and testis having higher complexity in that they expressed more genes and had more diverse mRNA populations. This increased transcriptome complexity may stem from the presence of more heterogeneous cell types in brain and testis or from a need for more diverse protein repertoires. The lower complexity observed in liver, muscle and heart presumably reflects more specialized functions of these tissues. Our FRACT analysis estimated the fraction of mRNA populations devoted to biological processes that are more specific for muscle and liver cells, such as muscle contraction, metabolism, electron transport and acute-phase response. At this point we have only static pictures of the functional allocation of mRNA resources across tissues and cell lines. Following the dynamic regulation of mRNA allocations during developmental or disease progression would therefore be of great interest, and might lead to robust gene expression signatures that are diagnostic of cellular state.
Many studies (e.g.
Previous studies using ESTs and microarrays have found a bias towards the usage of longer 3′UTRs in brain tissues
It was striking how many protein-coding genes were expressed in all samples studied, even including many transcription factors. This pattern could help in identifying determinants of cell identity and responses, as ubiquitous genes are less interesting candidates and could be discarded or separated when clustering samples by gene expression. It could also make it easier to select candidate disease genes after genetic linkage or association studies as ubiquitous genes are less involved in hereditary diseases
We used short read data from human tissues from
We mapped read positions onto gene models and estimated gene densities as the number of reads divided by the number of read start positions. We used only reads that mapped uniquely to the genome, and only positions where a read could potentially map uniquely counted toward exon length. For testing different ways of measuring gene expression (by removing different parts of the gene structure), we selected a set of genes with >2 exons and only one annotated isoform in RefSeq whose expressions had been measured by the MicroArray Quality Control project
For three mouse tissues, we calculated RPKM values in the same way as had been done for the human ones. Mouse genes were matched to human orthologs using Entrez Gene. A list of acute-phase genes was taken from
RefSeq gene annotation was used for protein-coding RNA (i.e. accessions starting with NM_) and curated non-coding RNA (NR_). We used the liftOver tool from the UCSC genome browser to obtain human positions for lincRNA regions from
GO annotations for Ensembl transcripts were downloaded from Ensembl (BioMart). The read density for each transcript in each tissue was distributed among its annotated GO categories (total transcript density/no. GO categories for the transcript). GO categories were sorted by the total transcriptome density across tissues and cell lines, and the 400 categories with greatest density (accounting for 94% of total density) were aggregated into 17 broad classes; the remaining categories (6% of total transcriptome density) were aggregated into an “other” class (see
The UTR lengths were calculated as the number of reads in a UTR divided by the number of reads in CDS multiplied by the CDS length. For the expression weighted average gene lengths, we used the CDS length from Refseq gene annotation, but weighted according to the expression of each gene. To see the correlation between mRNA length and abundance, we took the CDS length from RefSeq annotation for gene isoforms and added UTR length according to the distribution of reads in the three regions. Only those expressed above 0.3 RPKM were included, in order to exclude genes with few reads that could drive an artificial correlation. To compare 3′ bias between samples, i.e. to what extent genes get more reads as you go in the 3′ direction, we plotted the average read density for all genes (weighted so that each gene contributed equally) across the coding region and fit a line y = kx+m where y = read density, x = location along coding region, and k/m is a measure of 3′ bias.
Tissue transcriptome data used
(0.25 MB PDF)
Click here for additional data file.
Gene expression estimates using different gene models
(0.66 MB PDF)
Click here for additional data file.
Folding of 3′UTR and expression level estimates
(0.19 MB PDF)
Click here for additional data file.
Estimation of false discovery and negative rates at different expression levels
(0.38 MB PDF)
Click here for additional data file.
Estimation of false discovery and negative rates at different expression levels
(0.24 MB PDF)
Click here for additional data file.
Read density across genes
(0.17 MB PDF)
Click here for additional data file.
Gene expression for genes with multiple mRNA isoforms
(0.19 MB PDF)
Click here for additional data file.
Ubiquitously expressed human genes
(0.45 MB XLS)
Click here for additional data file.
Enriched gene ontology categories among ubiquitous genes
(0.16 MB XLS)
Click here for additional data file.
Enriched gene ontology categories among non-ubiquitous genes
(0.14 MB XLS)
Click here for additional data file.
Functional Relative Allocation of Transcripts
(0.17 MB XLS)
Click here for additional data file.
We would like to thank the anonymous reviewers for their valuable suggestions.
The authors have declared that no competing interests exist.
This research was supported by the Health Sciences and Technology NIH training grant (ETW), research grants from the NIH (CBB), research grants from the Swedish Foundation for Strategic Research, Knut and Alice Wallenbergs Foundation and Ake Wibergs Foundation (RS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.